Two sickle cell disease researchers will share a $3 million Breakthrough Prize for discoveries that changed the treatment ...

Etavopivat improved hemoglobin levels and reduced pain crises in a Phase 3 sickle cell disease trial, supporting potential ...

Newly diagnosed with DVT and a pulmonary embolism, columnist Michelle Harlan finds herself in an unfamiliar relationship with ...

People with sickle cell disease in Africa are less likely to use common treatments and may report lower burden, a global ...

Having a remote job has been a game-changer for me as someone with sickle cell disease. I’m better able to manage my health — no rushed mornings, cold commutes, or physical strain. I can plan my day ...

Bias in sickle cell care may be tied to opioid stigma, with patients more often described negatively in medical records, a ...

The isolation of chronic disease isn't just about being physically alone; it's also emotional and social, says columnist ...

The U.S. Food and Drug Administration has granted orphan drug status to Kind Pharmaceuticals’ investigational oral small molecule AND017 to treat sickle cell disease (SCD). This designation is granted ...

FTX-6058 is an experimental small molecule treatment for sickle cell disease (SCD) being developed by Fulcrum Therapeutics. It aims to treat patients by raising levels of fetal hemoglobin in cells.

It is incredibly important for those of us with sickle cell to stay hydrated. Drinking water promotes healthy blood flow and reduces the chance of our red blood cells sickling and sticking together.

Sickle cell anemia is an inherited blood disorder that can cause debilitating pain crises and put patients at increased risk for infections, among other symptoms. There are several treatments that can ...

A European Medicines Agency committee has issued a positive opinion on the gene-editing therapy Casgevy (exagamglogene autotemcel) in treating sickle cell disease (SCD) and transfusion-dependent beta ...